APOE Protein (Myc-DYKDDDDK Tag)
Kurzübersicht für APOE Protein (Myc-DYKDDDDK Tag) (ABIN2714829)
Target
Alle APOE Proteine anzeigenProtein-Typ
Spezies
Quelle
Applikation
Reinheit
-
-
Aufreinigungstag / Konjugat
- Dieses APOE Protein ist gelabelt mit Myc-DYKDDDDK Tag.
-
Produktmerkmale
-
- Recombinant human Apolipoprotein E / Apo E protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
-
-
Möchten Sie weitere Optionen für dieses Protein ?
!Entdecken Sie unsere vordefinierten maßgeschneiderten Proteine und Proteinservices!Ihr Projekt erfordert weitere Anpassungen? Kontaktieren Sie uns und entdecken Sie unsere maßgeschneiderten Proteinlösungen
-
-
-
Applikationshinweise
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays -
Kommentare
-
The tag is located at the C-terminal.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 50 μg/mL
-
Buffer
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
-
Lagerung
- -80 °C
-
Informationen zur Lagerung
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
-
-
Static and turnover kinetic measurement of protein biomarkers involved in triglyceride metabolism including apoB48 and apoA5 by LC/MS/MS." in: Journal of lipid research, Vol. 55, Issue 6, pp. 1179-87, (2016) (PubMed).
: "
-
Static and turnover kinetic measurement of protein biomarkers involved in triglyceride metabolism including apoB48 and apoA5 by LC/MS/MS." in: Journal of lipid research, Vol. 55, Issue 6, pp. 1179-87, (2016) (PubMed).
-
- APOE (Apolipoprotein E (APOE))
-
Andere Bezeichnung
- Apolipoprotein E,apo E
-
Hintergrund
- The protein encoded by this gene is a major apoprotein of the chylomicron. It binds to a specific liver and peripheral cell receptor, and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. This gene maps to chromosome 19 in a cluster with the related apolipoprotein C1 and C2 genes. Mutations in this gene result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants.
-
Molekulargewicht
- 34.2 kDa
-
NCBI Accession
- NP_000032
-
Pathways
- Regulation of Cell Size, Lipid Metabolism
Target
-